Compare Imperial Oil Limited Common Stock (IMO) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Imperial Oil Limited Common Stock vs Immunovant Inc. Common Stock — how do they compare? Imperial Oil Limited Common Stock trades at $129.6 (market cap $62.22B), while Immunovant Inc. Common Stock trades at $27.97 (market cap $5.93B). The key difference: Imperial Oil Limited Common Stock is far larger — about 10.5× Immunovant Inc. Common Stock's market cap, and Imperial Oil Limited Common Stock pays a 1.9% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IMO | IMVT | |
|---|---|---|
Market Cap | $62.22B | $5.93B |
Volume | 560,544 | 1,242,632 |
Sector | Energy | Health |
52-Week High | $138.33 | $44.96 |
52-Week Low | $83.72 | $17.41 |
Enterprise Value | $63.13B | $5.03B |
Dividend Yield | 1.9% | — |
Typical Hold Time | — | 6 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Immunovant (IMVT) trades at $28.71, down 2.61% with bearish technical signals despite strong analyst support. The company shows no revenue with substantial losses (-$413.84M net income) and negative margins, though it maintains a robust cash position from recent financing. Recent clinical setbacks, including the discontinuation of IMVT-1402 for cutaneous lupus, have pressured the stock, while multiple law firm investigations into potential fiduciary breaches add uncertainty.
The investment case hinges on IMVT-1402's success in other indications like Graves' disease, with a bullish analyst consensus (78% buy ratings) contrasting high execution risks. Key risks include clinical trial outcomes, cash burn, and legal overhangs. The stock's viability depends heavily on pipeline progress against a backdrop of persistent losses and volatile sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Imperial Oil Limited Common Stock
Imperial Oil Limited is a Canadian integrated energy company that explores for and produces crude oil and natural gas, operates oil sands projects at Cold Lake, Kearl, and Syncrude, and refines and markets petroleum products under the Esso and Mobil brands. ExxonMobil Corporation holds a majority ownership stake in the company.
Read more on IMO →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
